Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRENECAL trial of oral potassium citrate for prevention of nephrocalcinosis in extremely preterm infants
2012-000298-22Phase 3Completed
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in nephrocalcinosis comparing Potassium citrate with Placebo (2 arms). Primary endpoint: Incidence of nephrocalcinosis. Started May 2012; status: completed.
02
Drugs
potassium citrate
03
Conditions
nephrocalcinosis
Beyond the preview
Go deeper on 2012-000298-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000298-22.